Human renal‐cell carcinoma tissue contains dendritic cells

No abstract is available for this paper.

• Publication year

  1996

• Venue

  International Journal of Cancer

• Publication date

  1996-09-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0215(19960927)68:1<1::AID-IJC1>3.0.CO;2-VPMID 8895531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

  1996cited by this paper
• Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

  1995cited by this paper
• Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

  1995cited by this paper
• Lack of interleukin‐2 (IL‐2) expression and selective expression of IL‐10 mRNA in human renal cell carcinoma

  1995cited by this paper
• A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells.

  1995cited by this paper
• Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines.

  1995cited by this paper
• Tumor‐infiltrating T lymphocytes from renal‐cell carcinoma express B7‐1 (CD80): T‐Cell expansion by T‐T cell co‐stimulation

  1995cited by this paper
• Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates.

  1995cited by this paper
• Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1

  1995cited by this paper
• Maturation and migration of cutaneous dendritic cells.

  1995cited by this paper
• Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cells

  1995cited by this paper
• Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.

  1995cited by this paper
• Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.

  1995cited by this paper
• Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40‐ligand) and TNF‐α, but strongly enhanced by interleukin‐10

  1995cited by this paper
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

  1994cited by this paper
• Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen

  1994cited by this paper
• Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces

  1994cited by this paper
• Signals and signs for lymphocyte responses.

  1994cited by this paper
• The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro

  1994cited by this paper
• Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use

  1994cited by this paper
• Isolation and characterization of dendritic cells from mouse heart and kidney.

  1994cited by this paper
• Proliferating dendritic cell progenitors in human blood

  1994cited by this paper
• B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells

  1994cited by this paper
• Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity.

  1994cited by this paper
• Renal cell carcinoma : immunotherapy and cellular biology

  1993cited by this paper
• Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.

  1993cited by this paper
• Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.

  1993cited by this paper
• Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization.

  1993cited by this paper
• Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture

  1992cited by this paper
• GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

  1992cited by this paper
• GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.

  1992cited by this paper
• The dendritic cell system and its role in immunogenicity.

  1991cited by this paper

• Dendritic cells in the tumor microenvironment: prognostic and theranostic impact.

  2020cites this paper
• mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment

  2019cites this paper
• Interplay between dendritic cells and cancer cells.

  2019cites this paper
• Human Tumor-Infiltrating Dendritic Cells: From In Situ Visualization to High-Dimensional Analyses

  2019cites this paper
• A history of exploring cancer in context

  2018cites this paper
• IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers

  2018cites this paper
• Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine

  2018cites this paper
• Understanding Metabolic Adaptation of T Cells during Activation and Nutrient Limitation

  2018cites this paper
• The Efficacy of CIK-Based Immunotherapies for Advanced Solid Tumors

  2017cites this paper
• Dendritic cells based immunotherapy.

  2017cites this paper
• IL1 genes polymorphism and the risk of renal cell carcinoma in Chinese Han population

  2017cites this paper
• Dendritic Cells Inhibited by Tumor-Derived Antigen-Processing Machinery in Human Restoration by IL-15 of MHC Class I

  2017cites this paper
• Regulation of Natural Killer Cell Function by STAT3

  2016cites this paper
• Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells

  2016cites this paper
• Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy

  2015cites this paper
• Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis

  2015cites this paper
• Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma.

  2015cites this paper
• Personalized immunotherapy (AGS-003) when combined with sunitinib for the treatment of metastatic renal cell carcinoma

  2015cites this paper
• Biophysical Characteristics of DCs in Tumor Microenvironment

  2015cites this paper
• S100-positive dendritic cells in squamous cell laryngeal cancer.

  2014cites this paper
• A novel personalized vaccine approach in combination with targeted therapy in advanced renal cell carcinoma.

  2014cites this paper
• Immunotherapy in Renal Cell Carcinoma

  2014cites this paper
• Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors

  2014cites this paper
• The Promise of Oncoimmunology: Integrating Immunotherapy with Conventional Cancer Treatments

  2014cites this paper
• Role of langerin-positive and CD83+ cells in the pathogenesis of mycosis fungoides

  2013cites this paper
• Relationship of TGF‐β1 and Smad7 expression with decreased dendritic cell infiltration in liver gastrointestinal cancer metastasis

  2013cites this paper
• A randomized controlled trial of postoperative tumor lysate-pulsed dendritic cells and cytokine-induced killer cells immunotherapy in patients with localized and locally advanced renal cell carcinoma.

  2012cites this paper
• Characterization of a Novel Dendritic Cell Population

  2012cites this paper
• CD83+ dendritic cells and Foxp3+ regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer

  2012cites this paper
• Deciphering the message broadcast by tumor-infiltrating dendritic cells.

  2012cites this paper
• Análise do fenômeno da imunotolerância na fotocarcinogênese em lábio

  2011cites this paper
• Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.

  2011cites this paper
• Expression of CD40, CD86, and HLA-DR in CD1c+ Myeloid Dendritic Cells Isolated from Peripheral Blood in Primary Adenocarcinoma of Lung

  2011cites this paper
• Dendritic cell-based immunotherapy : A promising approach for treatment of cancer

  2011cites this paper
• Uso de RNA de interferência (siRNA) para modulação da expressão das moléculas co-estimuladoras CD80 e CD86 em células dendríticas.

  2010cites this paper
• Association of IL‐4 −590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population

  2010cites this paper
• Tumorvakzinierung beim metastasierten Nierenzellkarzinom

  2010cites this paper
• Dendritic Cell Vaccines

  2010cites this paper
• 원발성 폐선암환자의 말초혈액에서 분리한 CD1c＋ 골수성 수지상 세포에서의 CD40, CD86 및 HLA-DR의 발현

  2010cites this paper
• Immunoregulatory cells of the tumor microenvironment.

  2010cites this paper
• Dendritic cells in cancer

  2009cites this paper
• Immunosuppressive networks in the tumour environment and their effect in dendritic cells.

  2009cites this paper
• Expression and distribution of S-100, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in tissues of thyroid carcinoma.

  2009cites this paper
• Progress in the use of immunotherapy to treat uterine cervical cancer.

  2009cites this paper
• Functional Defects of Dendritic Cells in Cancer

  2009cites this paper
• A phase I/II trial of fixed-dose docetaxel plus irinotecan and escalating doses of estramustine phosphate for second-line or greater treatment of selected advanced solid tumors

  2009cites this paper
• Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma.

  2009cites this paper
• Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma

  2009cites this paper
• Progress in the use of Immunotherapy to Treat Uterine Cervical Cancer

  2009cites this paper
• Immunotherapy in renal cell carcinoma.

  2009cites this paper
• Immunoregulation by hepatocyte growth factor in malignant mesothelioma

  2008cites this paper
• Tumormilieu-induzierte Inaktivierung zytotoxischer Lymphozyten

  2008cites this paper
• The impact of Meth A fibrosarcoma derived EMAP II on dendritic cell migration.

  2008cites this paper
• Mycoplasma and tumors: synergistic effect on humanmonocyte-derived dendritic cells immunosuppressing activity

  2008cites this paper
• Prognostische Bedeutung der Expression von Indoleamine-2,3- dioxygenase (IDO) in Endothelzellen klarzelliger Nierenzellkarzinome

  2008cites this paper
• Development of a Dendritic Cell based Vaccine for the Immunotherapy of Acute Myeloid Leukaemia

  2008cites this paper
• Tumor-induced modulation of dendritic cell function.

  2008influential citation
• Dendritic Cells in Barrett’s Esophagus and Esophageal Adenocarcinoma

  2008cites this paper
• Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma.

  2008cites this paper
• International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine

  2007cites this paper
• Mécanisme d'action et fonction d'une sous-population de cellules dendritiques cytotoxiques chez le rat

  2007cites this paper
• Dendritic cell vaccine strategies for renal cell carcinoma

  2007cites this paper
• In Melanoma Changes of Immature and Mature Dendritic Cell Expression Correlate with Tumor Thickness: An Immunohistochemical Study

  2007cites this paper
• Apoptic Renal Carcinoma Cells are Better Inducers of Cross-Presenting Activity than Their Primary Necrotic Counterpart

  2007cites this paper
• International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine

  2007cites this paper
• Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma.

  2007cites this paper
• IRX-2, a Novel In Vivo Immunotherapeutic, Induces Maturation and Activation of Human Dendritic Cells In Vitro

  2007cites this paper
• Interleukin-4 Promoter Polymorphisms: A Genetic Prognostic Factor for Survival in Metastatic Renal Cell Carcinoma

  2007cites this paper
• Immune suppression in renal cell carcinoma.

  2007cites this paper
• Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton.

  2007cites this paper
• Tumor-derived lactic acid modulates dendritic cell activation and antigen expression.

  2006cites this paper
• Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?

  2006cites this paper
• Deficiences in phenotype expression and function of dentritic cells from patients with early breast cancer.

  2006cites this paper
• IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses

  2006cites this paper
• Dendritic cells heterogeneity and its role in cancer immunity.

  2006cites this paper
• Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients.

  2006cites this paper
• Brave Little World: Spheroids as an in vitro Model to Study Tumor-Immune-Cell Interactions

  2006cites this paper
• Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia

  2006cites this paper
• Expression and significance of tumor infiltrating dendritic cells in renal cell carcinoma

  2005cites this paper
• A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma

  2005cites this paper
• Dendritic cell-based immunotherapy: A promising approach for treatment of cancer

  2005cites this paper
• Gangliosides Dendritic Cells Inhibited by Tumor-Derived Antigen-Processing Machinery in Human Restoration by IL-15 of MHC Class

  2005cites this paper
• Antigen targeting to dendritic cells with bispecific antibodies.

  2005cites this paper
• Cytotoxicity and Activation of NK Cell-Mediated Dendritic Cells: Direct Tumor Cell Killing Tumoricidal Potential of Native Blood

  2005cites this paper
• Prognostic value of CD83-positive mature dendritic cells and their relation to vascular endothelial growth factor in advanced human gastric cancer.

  2005cites this paper
• Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells

  2005cites this paper
• Restoration by IL-15 of MHC Class I Antigen-Processing Machinery in Human Dendritic Cells Inhibited by Tumor-Derived Gangliosides1

  2005cites this paper
• Dendritic cell-based cancer immunotherapy targeting MUC-1

  2005cites this paper
• Irradiated Pancreatic Cancer Cells Undergo both Apoptosis and Necrosis, and Could Be Phagocytized by Dendritic Cells

  2005cites this paper
• Tumoricidal Potential of Native Blood Dendritic Cells: Direct Tumor Cell Killing and Activation of NK Cell-Mediated Cytotoxicity1

  2005cites this paper
• Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1ahighCD86−Langerin‐ and CD1a+CD86+Langerin+ phenotypes

  2004cites this paper
• Dendritic cells are dysfunctional in patients with operable breast cancer

  2004cites this paper
• Neuroblastoma and dendritic cell function.

  2004cites this paper
• Mechanisms and functional significance of tumour-induced dendritic-cell defects

  2004cites this paper
• Genetic engineering of TNF family protein-based vaccines for antitumor immunotherapy

  2004cites this paper
• Malfunction of the Dendritic Cell System in Cancer

  2004cites this paper
• Prolonged neoadjuvant treatment plus GM-CSF in locally advanced breast cancer: clinical and biological concepts

  2004cites this paper
• Bombesin/gastrin‐releasing peptide receptors in the basolateral amygdala regulate memory consolidation

  2004cites this paper
• Renal Cancer Vaccines

  2004cites this paper
• Intrahippocampal infusion of the bombesin/gastrin-releasing peptide antagonist RC-3095 impairs inhibitory avoidance retention.

  2003cites this paper